Literature DB >> 8837160

Evidence for limited validity of the revised global assessment of functioning scale.

P Roy-Byrne1, C Dagadakis, J Unutzer, R Ries.   

Abstract

The study examined the concurrent validity of the revised Global Assessment of Functioning (GAF) scale, which is highly similar to the Social and Occupational Functioning Assessment Scale (SOFAS) in DSM-IV and which is designed to measure patients' functioning and not their clinical symptoms. Psychiatrists used the revised GAF to rate 337 psychiatric inpatients; the ratings were compared with nurses' ratings of the same sample using Lehman's Quality of Life Scale. Ratings on the revised GAF were most strongly correlated with ratings of clinical symptoms, not functioning. Reliance on the GAF as the only tool to assess patients' functioning may be problematic.

Entities:  

Mesh:

Year:  1996        PMID: 8837160     DOI: 10.1176/ps.47.8.864

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  26 in total

1.  Statewide replication of predictive validation for the Multnomah Community Ability Scale.

Authors:  B Zani; B McFarland; M Wachal; S Barker; N Barron
Journal:  Community Ment Health J       Date:  1999-06

2.  Global Assessment of Functioning (GAF): properties and frontier of current knowledge.

Authors:  I H Monrad Aas
Journal:  Ann Gen Psychiatry       Date:  2010-05-07       Impact factor: 3.455

3.  Further validation of the Psycho-Social Well-Being Scale (PSWS) with community clients.

Authors:  Thomas O'Hare; Margaret V Sherrer; Hilary Smith Connery; Jay Thornton; Annamaria LaButti; Kelly Emrick
Journal:  Community Ment Health J       Date:  2003-04

Review 4.  Measurement of functional capacity: a new approach to understanding functional differences and real-world behavioral adaptation in those with mental illness.

Authors:  Thomas L Patterson; Brent T Mausbach
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

Review 5.  A review of instruments for measuring functional recovery in those diagnosed with psychosis.

Authors:  Brent T Mausbach; Raeanne Moore; Christopher Bowie; Veronica Cardenas; Thomas L Patterson
Journal:  Schizophr Bull       Date:  2008-11-20       Impact factor: 9.306

6.  Effects of Endurance Training Combined With Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients.

Authors:  Berend Malchow; Katriona Keller; Alkomiet Hasan; Sebastian Dörfler; Thomas Schneider-Axmann; Ursula Hillmer-Vogel; William G Honer; Thomas G Schulze; Andree Niklas; Thomas Wobrock; Andrea Schmitt; Peter Falkai
Journal:  Schizophr Bull       Date:  2015-03-17       Impact factor: 9.306

7.  Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder.

Authors:  Brent T Mausbach; Philip D Harvey; Ann E Pulver; Colin A Depp; Paula S Wolyniec; Mary H Thornquist; James R Luke; John A McGrath; Christopher R Bowie; Thomas L Patterson
Journal:  Bipolar Disord       Date:  2010-02       Impact factor: 6.744

8.  The incremental value of self-reported mental health measures in predicting functional outcomes of veterans.

Authors:  Susan V Eisen; Kathryn A Bottonari; Mark E Glickman; Avron Spiro; Mark R Schultz; Lawrence Herz; Robert Rosenheck; Ethan S Rofman
Journal:  J Behav Health Serv Res       Date:  2011-04       Impact factor: 1.505

9.  Visual form perception: a comparison of individuals at high risk for psychosis, recent onset schizophrenia and chronic schizophrenia.

Authors:  D Kimhy; C Corcoran; J M Harkavy-Friedman; B Ritzler; D C Javitt; D Malaspina
Journal:  Schizophr Res       Date:  2007-09-19       Impact factor: 4.939

10.  A network-based system to improve care for schizophrenia: the Medical Informatics Network Tool (MINT).

Authors:  Alexander S Young; Jim Mintz; Amy N Cohen; Matthew J Chinman
Journal:  J Am Med Inform Assoc       Date:  2004-06-07       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.